Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

From Architecture to Brain Imaging to Leader of a Major Academic Health System: John Mazziotta Talks with Johannes Czernin About an Evolving Career and Its Origins in Nuclear Medicine.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

The Research Post.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Dosimetry Analysis of <sup>177</sup>Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

The Patient Post.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Related Experiment Video

Updated: Feb 7, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.1K

Is This Whom We Have Become?

Johannes Czernin1

  • 1David Geffen School of Medicine at UCLA, Los Angeles, California.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|August 4, 2018
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example
05:45

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Published on: March 11, 2020

9.3K
Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis
06:56

Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis

Published on: September 22, 2023

1.7K

Related Experiment Videos

Last Updated: Feb 7, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.1K
Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example
05:45

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example

Published on: March 11, 2020

9.3K
Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis
06:56

Author Spotlight: Advancements in X-ray CT Tool Chain for Tree Core Analysis

Published on: September 22, 2023

1.7K